Myriad Genetics Inc. (MYGN) reported Loss for first quarter that decreased from last year but beat the Street estimates.
The company's bottom line came in at -$26.0 million, or -$0.29 per share. This compares with -$54.7 million, or -$0.67 per share, in last year's first quarter.
Excluding items, Myriad Genetics Inc. reported adjusted earnings of -$0.5 million or -$0.01 per share for the period.
Analysts on average had expected the company to earn -$0.10 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 11.6% to $202.2 million from $181.2 million last year.
Myriad Genetics Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$26.0 Mln. vs. -$54.7 Mln. last year.
-EPS (Q1): -$0.29 vs. -$0.67 last year.
-Revenue (Q1): $202.2 Mln vs. $181.2 Mln last year.
-Guidance:
Full year EPS guidance: $0.00 - $0.05
Full year revenue guidance: $820 - $840 Mln
For comments and feedback: editorial@rttnews.com